04 March 2025
Prof David Durrheim Services Director, Population Health
Dr. Coen Butters Paediatric Infectious Disease Consultant
Kylie Pratt Immunisations Nurse
A/Prof Rani Bhatia Paediatric Allergist and Immunologist
NSW Health NSW Immunisation Schedule. Updated February 2025
World Health Organisation Risk evaluation for SARS-CoV-2 Variant Under Monitoring: LP.8.1 Technical Advisory Group on Virus Evolution (TAG-VE), FEB 2025
Wang, Yawei et al. Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA.4/5, and XBB dominance in Hong Kong: a prospective cohort study The Lancet Infectious Diseases, Volume 25, Issue 3, 276 - 289
Kaufman, Jessica et al. Development and validation of the Vaccine Barriers Assessment Tool for identifying drivers of under-vaccination in children under five years in Australia. Human vaccines & immunotherapeutics vol. 20,1 (2024): 2359623. doi:10.1080/21645515.2024.2359623
NCIRS Current childhood immunisation coverage data
Centre for Disease Control Weekly US Influenza Surveillance Report: Key Updates for Week 5, ending February 1, 2025
Fazal A, Reinhart K, Huang S, et al. Reports of Encephalopathy Among Children with Influenza-Associated Mortality — United States, 2010–11 Through 2024–25 Influenza Seasons. MMWR Morb Mortal Wkly Rep 2025;74:91–95. DOI: http://dx.doi.org/10.15585/mmwr.mm7406a3.
Eden, John-Sebastian et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nature communications vol. 13,1 2884. 24 May. 2022, doi:10.1038/s41467-022-30485-3
Battles, Michael B, and Jason S McLellan. Respiratory syncytial virus entry and how to block it. Nature reviews. Microbiology vol. 17,4 (2019): 233-245. doi:10.1038/s41579-019-0149-x
Buonsenso, Danilo. RBivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants. The New England journal of medicine vol. 389,11 (2023): 1053. doi:10.1056/NEJMc2307729
Muller, William J et al. Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.. The New England journal of medicine vol. 388,16 (2023): 1533-1534. doi:10.1056/NEJMc2214773
Drysdale, Simon B et al. Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants. The New England journal of medicine vol. 389,26 (2023): 2425-2435. doi:10.1056/NEJMoa2309189
Griffin, M Pamela et al. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants. The New England journal of medicine vol. 383,5 (2020): 415-425. doi:10.1056/NEJMoa1913556
Australian Medicines Handbook Nirsevimab
Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook Australian Government Department of Health and Aged Care, Canberra, 2022, immunisationhandbook.health.gov.au.
Sharing Knowledge about Immunisation Respiratory syncytial virus (RSV)
Back